EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design

Søren S Olesen iD, Niels Henrik Bruun, Line Davidsen iD, Srdan Novovic, Stig B Laursen, Enrique de-Madaria iD, Dhiraj Yadav, Asbjørn M Drewes iD

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 976-984

DOI: 10.1111/apt.70820 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-06-25. Written by Søren S Olesen and 7 co-authors. Institution: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Major MEDLINE topics: Pancreatitis. Cited 3 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Patients with acute pancreatitis (AP) often experience recurrent acute pancreatitis (RAP), increasing the risk of chronic pancreatitis (CP) and long‐term complications. Progression along the AP–RAP–CP spectrum has been explored in epidemiological studies, but available data provide limited insight into recurrence dynamics within RAP itself. This information is crucial for the design of studies aiming to prevent RAP recurrence and disease progression.

Methods

In this nationwide cohort study, we included 45,338 Danish adults hospitalised with an incident episode of AP between January 1, 2000, and December 31, 2022, identified through national health registries. RAP was defined as recurrent hospitalisations for AP separated by ≥ 90 days. Competing risk models with pseudo‐observations estimated cumulative incidence functions for RAP recurrence stratified by the number of prior AP episodes. Inter‐episode intervals were estimated using Weibull models.

Results

During a median follow‐up of 4.5 years, 6894 patients developed RAP, corresponding to a 15.2% risk (95% confidence interval, 14.9%–15.5%). The RAP recurrence risk increased with accumulating episodes. The 12‐month cumulative incidence of RAP recurrence rose from 17% after one RAP episode to 46% after five episodes. Most recurrences occurred within 12 months, and inter‐episode intervals shortened with increasing episode number. Weibull models demonstrated a wear‐out pattern, with shape parameters increasing progressively across successive RAP episodes, indicating accelerating recurrence risk over time.

Conclusions

RAP follows an accelerating course characterised by increasing recurrence risk. Risk‐enriched trial designs targeting patients with more prior episodes may improve the feasibility and statistical efficiency of future interventional studies.

Subjects

MeSH terms (MEDLINE)

PancreatitisHumansRecurrenceFemaleDenmarkMaleAcute DiseaseMiddle AgedAdultDisease ProgressionCohort StudiesAgedIncidenceRisk FactorsHospitalizationPancreatitis, Chronic

Authors and institutions

  • Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Research Data and Biostatistics, Aalborg University Hospital, Aalborg, Denmark.
  • Pancreatitis Centre East, Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
  • Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark.
  • Department of Gastroenterology, Dr. Balmis General University Hospital-ISABIAL, Alicante, Spain.

ORCID profiles: Søren S Olesen, Line Davidsen, Enrique de-Madaria, Asbjørn M Drewes

Cite

APA

Olesen, S. S., Bruun, N. H., Davidsen, L., Novovic, S., Laursen, S. B., de-Madaria, E., Yadav, D., & Drewes, A. M. (2026). Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design. Alimentary Pharmacology & Therapeutics, 64(7), 976-984. https://doi.org/10.1111/apt.70820

Vancouver

Olesen SS, Bruun NH, Davidsen L, Novovic S, Laursen SB, de-Madaria E, et al. Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design. Alimentary Pharmacology & Therapeutics. 2026;64(7):976-984. doi:10.1111/apt.70820

BibTeX
@article{Olesen2026,
  author = {Olesen, Søren S and Bruun, Niels Henrik and Davidsen, Line and Novovic, Srdan and Laursen, Stig B and de-Madaria, Enrique and Yadav, Dhiraj and Drewes, Asbjørn M},
  title = {Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {976--984},
  doi = {10.1111/apt.70820}
}
Start for free →